Open Access
Nat. Sci. Soc.
Volume 13, Number 4, Octobre-Décembre 2005
Page(s) 371 - 382
Section Article
Published online 07 February 2006
  • Alves, A.P., Medina, N.H., Cruz, A.A., 2002. Trachoma and ethnic diversity in the upper Rio Negro Basin of Amazonas State, Brazil, Ophthal. Epidemiol., 9, 29-34. [CrossRef] [Google Scholar]
  • Amato, M.P., Battaglia, M.A., Caputo, D., Fattore, G., Gerzeli, S., Pitaro, M., Reggio, A., Trojano, M.; Mu.S.I.C. Study Group, 2002. The costs of multiple sclerosis: a cross-sectional, multicenter cost-of-illness study in Italy, J. Neurol., 249, 152-163. [CrossRef] [MathSciNet] [PubMed] [Google Scholar]
  • Anttila, T., Saikku, P., Koskela, P., Bloigu, A., Dillner, J., Ikaheimo, I., Jellum, E., Lehtinen, M., Lenner, P., Hakulinen, T., Narvanen, A., Pukkala, E., Thoresen, S., Youngman, L., Paavonen, J., 2001. Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma, J. Am. Med. Assn., 285, 47-51. [CrossRef] [Google Scholar]
  • Balin, B.J., Gérard, H.C., Arking, E.J., Appelt, D.M., Branigan, P.J., Abrams, J.T., Whittum-Hudson, J.A., Hudson, A.P., 1998. Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain, Med. Microbiol. Immunol., 187, 23-42. [Google Scholar]
  • Beeri, M.S., Werner, P., Adar, Z., Davidson, M., Noy, S., 2002. Economic cost of Alzheimer's disease in Israel, Alzheimer Dis. Assoc. Disord., 16, 73-80. [CrossRef] [PubMed] [Google Scholar]
  • Belland, R.J., Ouellette, S.P., Gieffers, J., Byrne, G.I., 2004. Chlamydia pneumoniae and atherosclerosis, Cell. Microbiol., 6, 117-127. [CrossRef] [PubMed] [Google Scholar]
  • Campbell, L.A., Kuo, C.C., 2004. Chlamydia pneumoniae – an infectious risk factor for atherosclerosis, Nat. Rev. Microbiol., 2, 23-32. [CrossRef] [PubMed] [Google Scholar]
  • Carter, J.D., Valeriano, J., Vasey, F.B., 2004. Doxycycline vs. doxycycline and rifampin in undifferentiated spondyloarthropathy, with special reference to Chlamydia-induced arthritis. A prospective, randomized 9-month comparison, J. Rheumatol., 31, 1973-1980. [PubMed] [Google Scholar]
  • CDC website: chlamydiapneumoniae [Google Scholar]
  • Centers for Disease Control and Prevention, 2004. Sexually transmitted disease surveillance 2003 supplement, Chlamydia prevalence monitoring project annual report 2003, Atlanta, GA, US Department of Health and Human Services, Centers for Disease Control and Prevention. [Google Scholar]
  • Chesson, H.W., Blandford, J.M., Gift, T.L., Tao, G., Irwin, K.L., 2004. The estimated direct medical cost of sexually transmitted diseases among American youth, 2000, Perspect. Sex. Reprod. Health 36, 11-19. [CrossRef] [Google Scholar]
  • Ciervo, A., Petrucca, A., Cassone, A., 2003. Identification and quantification of Chlamydia pneumoniae in human atherosclerotic plaques by LightCycler real time PCR, Mol. Cell. Probes., 17, 107-111. [CrossRef] [PubMed] [Google Scholar]
  • Clementsen, P., Permin, H., Norn, S., 2002. Chlamydia pneumoniae infection and its role in asthma and chronic obstructive pulmonary disease, J. Investigat. Allergol. Clin. Immunol., 12, 73-79. [Google Scholar]
  • Corsaro, D., Valassina, M., Venditti, D., 2003. Increasing diversity with Chlamydia, Crit. Rev. Microbiol., 29, 37-78. [Google Scholar]
  • Corsaro, D., Venditti, D., 2004. Emerging chlamydial infections, Crit. Rev. Microbiol., 30, 75-106. [CrossRef] [PubMed] [Google Scholar]
  • Debattista, J., Martin, P., Jamieson, J., Crane, K., Dolton, I., Russell-Hall, S., DeSilva, J., Hargrave, R., Robinson, T., Ryan, N., Mortlock, M., 2002. Detection of Chlamydia trachomatis in an Australian high school student population, Sex. Transm. Dis., 78, 194-197. [CrossRef] [Google Scholar]
  • Fox, P.J., Kohatsu, N., Max, W., Arnsberger, P., 2001. Estimating the costs of caring for people Alzheimer's disease in California: 2000-2040, J. Publ. Health Policy, 22, 88-97. [CrossRef] [MathSciNet] [Google Scholar]
  • Frick, K.D., Arantxa-Colchero, M., Dean, D., 2004. Modeling the economic net benefit of a potential vaccination program against ocular infection with Chlamydia trachomatis, Vaccine, 22, 690-697. [CrossRef] [Google Scholar]
  • Garbino, J., Sommer, R., Gerber, A., Regamey, C., Vernazza, P., Genne, D., Dur, P., Rothen, M., Unger, J.P., Lew, D., 2002. Prospective epidemiologic survey of patients with community acquired pneumonia requiring hospitalization in Switzerland, Int. J. Infect. Dis., 6, 288-293. [CrossRef] [PubMed] [Google Scholar]
  • Gérard, H.C., Branigan, P.J., Balsara, G.R., Heath, C., Minassian, S.S., Hudson, A.P., 1998. Viability of Chlamydia trachomatis in fallopian tubes of patients with ectopic pregnancy, Fertil. Steril., 70, 945-948. [CrossRef] [PubMed] [Google Scholar]
  • Gerbase, A.C., Mertens, T.E., 1998. Sexually transmitted diseases in Africa: a time for action, Afr. Health, 20, 10-12. [PubMed] [Google Scholar]
  • Gerbase, A.C., Rowley, J.T., Heymann, D.H., Berkley, S.F., Piot, P., 1998. Global prevalence and incidence estimates of selected curable STDs, Sex. Transm. Infect., 74 (suppl. 1), S12-S16. [PubMed] [Google Scholar]
  • Grayston, J.T., 1992. Chlamydia pneumoniae, strain TWAR pneumonia, Annu. Rev. Med., 43, 317-323. [CrossRef] [PubMed] [Google Scholar]
  • Grayston, J.T., Kronmal, R.A., Jackson, L.A., Parisi, A.F., Muhlestein, J.B., Cohen, J.D., Rogers, W.J., Crouse, J.R., Borrowdale, S.L., Schron, E., Knirsch, C. for the ACES investigators, 2005. Azithromycin for the secondary prevention of coronary events, N. Engl. J. Med., 352, 1637-1645. [CrossRef] [PubMed] [Google Scholar]
  • Greub, G., Mege, J.-L., Raoult, D., 2003a. Parachlamydia acanthamoebae enters and multiplies within human macrophages and induces their apoptosis, Infect. Immun., 71, 5979-5985. [CrossRef] [PubMed] [Google Scholar]
  • Erratum: 2004, Infect. Immun., 72, 621. [CrossRef] [Google Scholar]
  • Greub, G., Boyadjiev, I., LaScola B., Raoult, D., Martin C., 2003b. Serological hint suggesting that Parachlamydiaceae are agents of pneumonia in polytraumatized intensive care patients, Ann. N.Y. Acad. Sci., 990, 311-319. [CrossRef] [Google Scholar]
  • Grio, R., Latino, M.A., Leotta, E., Smirne, C., Lanza, A., Spagnolo, E., Perozziello, A., Caneparo, A., Bello, L., Lerro, R., 2004. Sexually transmitted diseases and pelvic inflammatory disease, Minerva Ginecol., 56, 141-147. [PubMed] [Google Scholar]
  • Groot, W., Van Den Brink, H.M., Plug, E., 2004. Money for health: the equivalent variation of cardiovascular diseases, Health Econ., 13, 850-872. [CrossRef] [Google Scholar]
  • Guaschino, S., De Seta, F./, 2000. Update on Chlamydia trachomatis, Ann. N.Y. Acad. Sci., 900, 293-300. [CrossRef] [Google Scholar]
  • Hahn, D.L., Azenabor, A.A., Beatty, W.L., Byrne, G.I., 2002. Chlamydia pneumoniae as a respiratory pathogen, Front. Biosci., 7, e66-e76. [CrossRef] [PubMed] [Google Scholar]
  • Hatch, T.P., 1999. Developmental biology, in Stephens, R.S. (Ed.), Chlamydia - Intracellular biology, Pathogenesis, and Immunity, Washington DC, ASM Press. [Google Scholar]
  • Heddema, E.R., Kraan, M.C., Buys-Bergen, H.E., Smith, H.E., Wertheim-van Dillem, P.M., 2003. A woman with a lobar infiltrate due to psittacosis detected by polymerase chain reaction, Scan. J. Infect. Dis., 35, 422-424. [CrossRef] [Google Scholar]
  • Hogan, R.J., Mathews, S.A., Mukjopadhyay, S., Summersgill, J.T., Timms, P., 2004. Chlamydial persistence: beyond the biphasic paradigm, Infect. Immun., 72, 1843-1855. [CrossRef] [PubMed] [Google Scholar]
  • Honey, E., Templeton, A., 2002. Prevention of pelvic inflammatory disease by control of C. trachomatis infection, Int. J. Gynaecol. Obstet., 78, 257-261. [CrossRef] [PubMed] [Google Scholar]
  • Hook, E.W., Peeling, R.W., 2004. Syphilis control – a continuing challenge, N. Engl. J. Med., 351, 122-124. [CrossRef] [PubMed] [Google Scholar]
  • Howell, M.R., Gaydos, J.C., McKee, K.T., Quinn, T.C., Gaydos, C.A., 1999. Control of Chlamydia trachomatis infections in female army recruits: cost-effective screening and treatment in training cohorts to prevent pelvic inflammatory disease, Sex. Transm. Dis., 26, 519-526. [CrossRef] [PubMed] [Google Scholar]
  • Ito, I., Ishida, T., Mishima, M., Osawa, M., Arita, M., Hashimoto, T., Kishimoto, T., 2002. Familal cases of psittacosis: possible person-to-person transmission, Intern. Med., 41, 580-583. [CrossRef] [PubMed] [Google Scholar]
  • Johnsen, S., Birkebaek, N., Andersen, P.L., Emil C., Jensen J.S., Ostergaard, I., 2005. Indirect immunofluorescence and real time PCR for detection of Simkania negevensis in Danish adults with persistent cough and in healthy controls, Scand. J. Infect. Dis., 37, 251-255. [PubMed] [Google Scholar]
  • Joyee, A.G., Thyagarajan, S.P., Rajendran, P., Hari, R., Balakrishnan, P., Jeyaseelan, L., Kurien, T., and the STD Study Group, 2004. Chlamydia trachomatis genital infection in an apparently healthy adult population of Tamil Nadu, India: a population-based study, Int. J. STD AIDS, 15, 51-55. [CrossRef] [PubMed] [Google Scholar]
  • Kahane, S., Platzner, N., Dvoskin, B., Itzhaki, A., Friedman, M.G., 2004. Evidence for the presence of Simkania negevensis in drinking water and in reclaimed wastewater in Israel, Appl. Environ. Microbiol., 70, 3346-3351. [CrossRef] [PubMed] [Google Scholar]
  • Kalayoglu, M.V., Byrne, G.I., 1998a. Induction of macrophage foam cell formation by Chlamydia pneumoniae, J. Infect. Dis., 177, 172-179. [CrossRef] [Google Scholar]
  • Kalayoglu, M.V., Byrne, G.I., 1998b. A Chlamydia pneumoniae component that induces macrophage foam cell formation is chlamydial lipopolysaccharide, Infect. Immun., 66, 5067-5072. [PubMed] [Google Scholar]
  • Kasi, P.M., Gilani, A.I., 2004. Trachoma still ignored in developing countries, Lancet, 363, 1736 (letter). [CrossRef] [Google Scholar]
  • Keefover, R.W., 1996. The clinical epidemiology of Alzheimer's disease, Neurol. Clin., 14, 337-351. [CrossRef] [PubMed] [Google Scholar]
  • Kelly, A.M., Ireland, M., Aughey, D., 2004. Pelvic inflammatory disease in adolescents: high incidence and recurrence rates in an urban teen clinic, J. Pediatr. Adolesc. Gynecol., 17, 383-388. [CrossRef] [PubMed] [Google Scholar]
  • Krause, W., Bohring, C., 2003. Male infertility and genital chlamydial infection: victim or perpetrator?, Andrologia, 25, 209-216. [CrossRef] [Google Scholar]
  • Kumaresan, J.A., Mecaskey, J.W., 2003. The global elimination of trachoma: progress and promise, Am. J. Trop. Med. Hyg., 69(5 suppl.), 24-28. [CrossRef] [PubMed] [Google Scholar]
  • LaMontagne, D.S., Fenton, K.A., Randall, S., Anderson, S., Carter, P. 2004. Establishing the National Chlamydia Screening Programme in England: results from the first full year of screening, Sex. Transm. Infect., 80, 335-341. [CrossRef] [PubMed] [Google Scholar]
  • Leinonen, M., 1993. Pathogenic mechanisms and epidemiology of Chlamydia pneumoniae, Eur. Heart J., 14 (suppl. K), 57-61. [CrossRef] [Google Scholar]
  • Lin, T.M., Kuo, C.C., Chen, W.J., Lin, F.J., Eng, H.L., 2004. Seroprevalence of Chlamydia pneumoniae infection in Taiwan, J. Infect. Dis., 48, 91-95. [Google Scholar]
  • Loeb, M.B., Molloy, D.W., Smieja, M., Standish, T., Goldsmith, C.H., Mahony, J., Smith, S., Borrie, M., Decoteau, E., Davidson, W., McDougall, A., Gnarpe, J., O'Donnell, M., Chernesky, M., 2004. A randomized controlled trial of doxycycline and rifampin for patients with Alzheimer's disease, J. Am. Geriatr. Soc., 52, 381-387. [CrossRef] [PubMed] [Google Scholar]
  • Longbottom, D., 2003. Chlamydial vaccine development, J. Med. Microbiol., 52, 537-540. [CrossRef] [PubMed] [Google Scholar]
  • Mabey, D.C., Solomon, A.W., Foster, A., 2003. Trachoma, Lancet, 362, 223-229. [CrossRef] [PubMed] [Google Scholar]
  • Mårdh, P.-A., 2004a. Tubal factor infertility, with special regard to chlamydial salpingitis, Curr. Opin. Infect. Dis., 17, 49-52. [CrossRef] [PubMed] [Google Scholar]
  • Mårdh, P.-A., 2004b. Surveillance – what we know and do not know about the spread of infections by Chlamydia trachomatis, in Deák, J. (Ed.), Proceedings of the Fifth Meeting of the European Society for Chlamydia Research, Budapest (Hungary), Pauker Nyomdaipari Kft. [Google Scholar]
  • Marrie, T.J., Peeling, R.W., Reid, T., DeCarolis, E.; Canadian Community Acquited Pneumonia Investigators, 2003. Chlamydia species as a cause of community acquired pneumonia in Canada, Eur. Respir. J., 21, 779-784. [CrossRef] [PubMed] [Google Scholar]
  • Masata, J., Drazdaková, M., Hruba, D., Rezacova, J., 2004. Prevalence of genital chlamydial infections among young females in Prague, in Deák, J. (Ed.) Proceedings of the Fifth Meeting of the European Society for Chlamydia Research, Budapest (Hungary), Pauker Nyomdaipari Kft. [Google Scholar]
  • Maza, L.M. de la, Peterson, E.M., 2002. Vaccines for Chlamydia trachomatis infections, Curr. Opin. Investig. Drugs, 3, 980-986. [PubMed] [Google Scholar]
  • Michelow, I.C., Olsen, K., Lozano, J., Rollis, N.K., Duffy, L.B., Ziegler, T., Kauppila, J., Leinonen, M., McCracken, G.H., 2004. Epidemiology and clinical characteristics of community acquired pneumonia in hospitalized children, Pediatrics, 113, 701-707. [CrossRef] [PubMed] [Google Scholar]
  • Miranda, A.E., Szwarcwald, C.L., Peres, R.L., Page-Shafer, K., 2004. Prevalence and risk behaviors for chlamydial infection in a population-based study of female adolescents in Brazil, Sex. Transm. Dis., 31, 542-546. [CrossRef] [PubMed] [Google Scholar]
  • Moazed, T.C., Kuo, C.C., Grayston, J.T., Campbell, L.A., 1998. Evidence of systemic dissemination of Chlamydia pneumoniae via macrophages in the mouse, J. Infect. Dis., 177, 1322-1325. [CrossRef] [PubMed] [Google Scholar]
  • Molano, M., Weiderpass, E., Posso, H., Morre, S.A., Ronderos, M., Franceschi, S., Arslan, A., Meijer, C.J., Monoz, N., van den Brule, A.J., and the HPV Study Group, 2003. Prevalence and determinants of Chlamydia trachomatis infections in women from Bogota, Columbia, Sex. Transm. Infect., 79, 474-478. [CrossRef] [PubMed] [Google Scholar]
  • Moxon, R., Rappuoli, R., 2002. Bacterial pathogen genomics and vaccines, Br. Med. Bull., 62, 45-58. [CrossRef] [PubMed] [Google Scholar]
  • Nusbaum, M.R., Wallace, R.R., Slatt, L.M., Dondrad, E.C., 2004. Sexually transmitted infections and increased risk of co-infection with human immunodeficiency virus, J. Am. Osteopath. Assn., 104, 527-535. [Google Scholar]
  • Parish, W.L., Laumann, E.O., Cohen, M.S., Pan, S., Zheng, H., Hoffman, I., Wang, T., Ng, K.H., 2003. Population-based study of chlamydial infection in China: a hidden epidemic, J. Am. Med. Assn., 289, 1265-1273. [CrossRef] [Google Scholar]
  • Powell, J., O'Connor, C., O'hlarlaithe, M., Saunders, J., DeFreitas, J., 2004. Chlamydia trachomatis prevalence in men in the mid-west of Ireland, Sex. Transm. Infect., 80, 349-353. [CrossRef] [PubMed] [Google Scholar]
  • Ragonese, P., Salemi, G., D'Amelio, M., Gammino, M., Aridon, P., Savettieri, G., 2004. Multiple sclerosis in southern Europe : Monreale City, Italy. A twenty year follow-up incidence and prevalence study, Neuroepidemiology, 23, 306-309. [CrossRef] [PubMed] [Google Scholar]
  • Rich, E., Hook, E.W., Alarcon, G.S., Moreland, L.W., 1996. Reactive arthritis in patients attending an urban sexually transmitted disease clinic, Arthritis Rheum., 39, 1172-1177. [CrossRef] [PubMed] [Google Scholar]
  • Rigaud, A.-S., Fagnani, F., Bayle, C., Latour, F., Traykov, L., Forette, F., 2003. Patients with Alzheimer's disease living at home in France: costs and consequences of the disease, J. Geriatr. Psychiatry Neurol., 16, 140-145. [CrossRef] [PubMed] [Google Scholar]
  • Saikku, P., Leinonen, M., Mattila, K., Ekman, M.R., Nieminen, M.S., Makela, P.H., Huttunen, J.K., Valtonen, V., 1988. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction, Lancet, 2, 983-986. [CrossRef] [PubMed] [Google Scholar]
  • Sarasoja, T., Wikstrom, J., Paltamaa, J., Hakama, M., Sumelahti, M.L., 2004. Occurrence of multiple sclerosis in central Finland: a regional and temporal comparison during 30 years, Acta Neurol. Scand., 110, 331-336. [CrossRef] [PubMed] [Google Scholar]
  • Schachter, J., 1999. Infection and disease epidemiology, in Stephens, R.S. (Ed.), Chlamydia: Intracellular Biology, Pathogenesis, and Immunity, Washington DC, ASM Press. [Google Scholar]
  • Schmidt, S.M., Muller, C.E., Krechting, M., Wiersbitzky, H., Gurtler, L., Wiersbitzky, S.K., 2003. Chlamydia pneumoniae carriage and infection in hospitalized children with respiratory tract diseases, Infection, 31, 410-416. [CrossRef] [PubMed] [Google Scholar]
  • Shimizu, C., Nabeshima, S., Kikuchi, K., Furusyo, N., Kashiwagi, S., Hayashi, J., 2002. Prevalence of antibody to Chlamydia pneumoniae in residents of Japan, the Solomon Islands, and Nepal, Am. J. Trop. Med. Hyg., 67, 170-175. [PubMed] [Google Scholar]
  • Smith, K.A., Bradley, K.K., Stobierski, M.G., Tengelsen, L.A., National Association of State Public Health Veterinarians Psittacosis Compendium Committee, 2005. Compendium of measures to control Chlamydophila psittaci (formerly Chlamydia psittaci) infection among humans (psittacosis) and pet birds, J. Am Vet. Med. Assoc., 226, 532-539. [CrossRef] [PubMed] [Google Scholar]
  • Soderlin, M.K., Borjesson, O., Kautianen, H., Skogh, T., Leirisalo-Repo, M., 2002. Annual incidence of inflammatory joint diseases in a population based in southern Sweden, Ann. Rheum. Dis., 61, 911-915. [CrossRef] [PubMed] [Google Scholar]
  • Sriram, S., Stratton, C.W., Yao, S., Tharp, A., Ding, L., Bannan, J.D., Mitchell, W.M., 1999. Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis, Ann. Neurol., 46, 6-14. [CrossRef] [PubMed] [Google Scholar]
  • Swanborg, R.H., Whittum-Hudson, J.A., Hudson, A.P., 2003. Infectious agents and multiple sclerosis – are human herpes virus 6 and Chlamydia pneumoniae involved?, J. Neuroimmunol., 136, 1-8. [CrossRef] [PubMed] [Google Scholar]
  • Taylor, H.R., 2001. Trachoma in Australia, Med. J. Aust., 175, 371-372. [PubMed] [Google Scholar]
  • Telfer, B.L., Moberley, S.A., Hort, K.P., Branley, J.M., Dwyer, D.E., Muscatello, D.J., Correll, PlK., England, J., McAunlty, J.M., 2005. Probable psittacosis outbreak linked to wild birds, Emerg. Infect. Dis., 11, 391-397. [CrossRef] [PubMed] [Google Scholar]
  • Tobin, J.M., Harindra, V., Mani, R., 2004. Which treatment for genital tract Chlamydia trachomatis infection?, Int. J. STD AIDS, 15, 737-739. [CrossRef] [PubMed] [Google Scholar]
  • Villareal, C., Whittum-Hudson, J.A., Hudson, A.P., 2002. Persistent Chlamydiae and chronic arthritis, Arthritis Res., 4, 5-9. [CrossRef] [PubMed] [Google Scholar]
  • Ward, M.E., 1999. Mechanisms of Chlamydia-induced pathogenesis, in Stephens, R.S. (Ed.), Chlamydia - Intracellular biology, Pathogenesis, and Immunity, Washington DC, ASM Press. [Google Scholar]
  • Watts, S., 1997. Epidemics and History, Disease, Power, and Imperialism, New Haven, Ct, Yale University Press. [Google Scholar]
  • West, S.K., 2004. Trachoma: new assault on an ancient disease, Prog. Ret. Eye Res., 23, 381-401. [CrossRef] [Google Scholar]
  • Whittum-Hudson, J.A., 1999. Prevention vs. treatment of Chlamydial infections: A novel experimental approach, Curr. Treatment Options Infect. Dis., 1, 88-92. [Google Scholar]
  • Whittum-Hudson, J.A., 2005. Ocular chlamydial infections, in Zierhut, M., Stern, M.E., Sullivan, D.A. (Eds), Immunology of the Lacrimal Gland, Tear Film and Ocular Surface, London, Taylor and Francis. [Google Scholar]
  • Whittum-Hudson, J.A., An, L.-L., MacDonald, A.B., Prendergast, R.A., Saltzman, W.M., 1996. Oral immunization with an anti-idiotypic antibody to the exoglycolipid antigen protects against experimental Chlamydia trachomatis infection, Nat. Med., 2, 1116-1121. [CrossRef] [PubMed] [Google Scholar]
  • Whittum-Hudson, J.A., Rudy, D., Gerard, H., Vora, G., Davis, E., Haller, P.K., Prattis, S.M., Hudson, A.P., Saltzman, W.M., Stuart, E.S., 2001. The anti-Idiotypic antibody to chlamydial glycolipid exoantigen (GLXA) protects mice against genital infection with a human biovar of Chlamydia trachomatis, Vaccine, 19, 4061-4071. [CrossRef] [PubMed] [Google Scholar]
  • Whittum-Hudson, J.A., Gérard, H.C., Schumacher, H.R., Hudson, A.P., 2004. Chlamydiae and inflammatory arthritis, in Columbus, F. (Ed.), Focus on Arthritis Research, Nova Science Publishers Inc., 175-199. [Google Scholar]
  • Whittum-Hudson, J.A., Gérard, H.C., Schumacher, H.R., Hudson, A.P., 2005a. Pathogenesis of Chlamydia-associated arthritis, in Bavoil, P., Wyrick, P. (Eds), Chlamydia – Pathogenesis and Treatments, Blackwell Publishing, Inc. In press. [Google Scholar]
  • Whittum-Hudson, J.A., Schumacher, H.R., Hudson, A.P., 2005b. Chlamydia pneumoniae and inflammatory arthritis, in Yamamoto, Y., Friedman, H., Bendinelli, M. (Eds), Chlamydia pneumoniae Infection and Diseases, New York, Kluwer/Academic Press, 227-238. [Google Scholar]
  • Yamaguchi, T., Yamazaki, T., Inoue, M., Mashida, C., Kawagoe, K., Ogawa, M., Shiga, S., Nakagawa, Y., Kishimoto, T., Kurane, I., Ouchi, K., Ohzeki, T., 2005. Prevalence of antibodies against Simkania negevensis in a healthy Japanese population determined by the microimmunofluorescence test, FEMS Immunol. Med. Microbiol., 43, 21-27. [CrossRef] [MathSciNet] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.